Home/Filings/4/0001048477-25-000035
4//SEC Filing

Hubbard Cristin 4

Accession 0001048477-25-000035

CIK 0001048477other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:25 PM ET

Size

6.9 KB

Accession

0001048477-25-000035

Insider Transaction Report

Form 4
Period: 2025-03-17
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-03-17+13,31032,700 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2025-03-17+30,88030,880 total
    Exercise: $71.55From: 2026-03-17Exp: 2035-03-16Common Stock (30,880 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted March 17, 2025. Price not applicable.
  • [F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0002021836

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:25 PM ET
Size
6.9 KB